Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 316

1.

Sacral Neuromodulation: Standardized Electrode Placement Technique.

Matzel KE, Chartier-Kastler E, Knowles CH, Lehur PA, Muñoz-Duyos A, Ratto C, Rydningen MB, Sørensen M, van Kerrebroeck P, de Wachter S.

Neuromodulation. 2017 Oct 4. doi: 10.1111/ner.12695. [Epub ahead of print]

PMID:
28975677
2.

Long-Term Functional Outcomes of S3 Sacral Neuromodulation for the Treatment of Idiopathic Overactive Bladder.

Ismail S, Chartier-Kastler E, Perrouin-Verbe MA, Rose-Dite-Modestine J, Denys P, Phé V.

Neuromodulation. 2017 Oct 2. doi: 10.1111/ner.12696. [Epub ahead of print]

PMID:
28967986
3.

Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivity.

Joussain C, Popoff M, Phé V, Even A, Bosset PO, Pottier S, Falcou L, Levy J, Vaugier I, Chartier Kastler E, Schurch B, Denys P.

Neurourol Urodyn. 2017 Jul 26. doi: 10.1002/nau.23352. [Epub ahead of print]

PMID:
28745807
4.

[Description of a clinical typology specific to men whose urinary symptoms require anticholinergic treatment].

Cornu JN, Descazeaud A, Chartier-Kastler E, Bourouina R.

Prog Urol. 2017 Sep;27(10):551-558. doi: 10.1016/j.purol.2017.06.003. Epub 2017 Jul 4. French.

PMID:
28687156
5.

[Placement of tension-free vaginal tape in women with stress urinary incontinence: Long-term functional outcomes in a prospective series].

Manach Q, Bouquot M, Rouprêt M, Ambrogi V, Richard F, Bitker MO, Chartier-Kastler E, Phé V.

Prog Urol. 2017 Oct;27(12):640-646. doi: 10.1016/j.purol.2017.05.009. Epub 2017 Jun 23. French.

PMID:
28651995
6.

[Pregnancy and delivery for women with congenital spinal cord defects and neurogenic bladder].

Manach Q, Dommergues M, Denys P, Loiseau K, Idiard-Chamois B, Chartier-Kastler E, Phé V.

Prog Urol. 2017 Oct;27(12):618-625. doi: 10.1016/j.purol.2017.05.007. Epub 2017 Jun 17. French.

PMID:
28629786
7.

Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).

Phé V, Schneider MP, Peyronnet B, Abo Youssef N, Mordasini L, Chartier-Kastler E, Bachmann LM, Kessler TM.

Neurourol Urodyn. 2017 Jun 15. doi: 10.1002/nau.23314. [Epub ahead of print] Review.

PMID:
28618110
8.

Ceftolozane/tazobactam for febrile UTI due to multidrug-resistant Pseudomonas aeruginosa in a patient with neurogenic bladder.

Dinh A, Davido B, Calin R, Paquereau J, Duran C, Bouchand F, Phé V, Chartier-Kastler E, Rottman M, Salomon J, Plésiat P, Potron A.

Spinal Cord Ser Cases. 2017 May 11;3:17019. doi: 10.1038/scsandc.2017.19. eCollection 2017.

PMID:
28503325
9.

Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis.

Abo Youssef N, Schneider MP, Mordasini L, Ineichen BV, Bachmann LM, Chartier-Kastler E, Panicker JN, Kessler TM.

BJU Int. 2017 Apr;119(4):515-521. doi: 10.1111/bju.13759. Epub 2017 Feb 23. Review.

PMID:
28058780
10.

[Medico-economic evaluation of urological cares of spinal cord injured patients: A review].

Guillot-Tantay C, Chartier-Kastler E, Manach Q, Perrouin-Verbe MA, Denys P, Phé V.

Prog Urol. 2017 Jan;27(1):3-9. doi: 10.1016/j.purol.2016.11.003. Epub 2016 Dec 14. Review. French.

PMID:
27988174
11.

[Continent cutaneous urinary diversion after cystectomy for cancer: A reliable alternative? A monocentric retrospective study].

Vuichoud C, Perrouin-Verbe MA, Phe V, Bitker MO, Parra J, Chartier-Kastler E.

Prog Urol. 2016 Sep - Oct;26(11-12):642-650. doi: 10.1016/j.purol.2016.09.061. Epub 2016 Oct 4. French.

PMID:
27717734
12.

Pregnancy in spinal cord-injured women, a cohort study of 37 pregnancies in 25 women.

Le Liepvre H, Dinh A, Idiard-Chamois B, Chartier-Kastler E, Phé V, Even A, Robain G, Denys P.

Spinal Cord. 2017 Feb;55(2):167-171. doi: 10.1038/sc.2016.138. Epub 2016 Sep 27.

PMID:
27670808
13.

Prospective evaluation of antibiotic treatment for urological procedure in patients presenting with neurogenic bladder.

Weglinski L, Rouzaud C, Even A, Bouchand F, Davido B, Duran C, Salomon J, Perronne C, Denys P, Chartier-Kastler E, Dinh A.

Med Mal Infect. 2016 Sep;46(6):300-7. doi: 10.1016/j.medmal.2016.04.001. Epub 2016 May 27.

PMID:
27241225
14.

[Prevalence and initial management of overactive bladder in France: A cross-sectional study].

Cornu JN, Amarenco G, Bruyere F, Chartier-Kastler E, Fatton B, Grise P, Haab F, Bourouina R.

Prog Urol. 2016 Jun;26(7):415-24. doi: 10.1016/j.purol.2016.04.002. Epub 2016 Apr 20. French.

PMID:
27108102
15.

Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment.

Rovner E, Kohan A, Chartier-Kastler E, Jünemann KP, Del Popolo G, Herschorn S, Joshi M, Magyar A, Nitti V.

J Urol. 2016 Sep;196(3):801-8. doi: 10.1016/j.juro.2016.04.046. Epub 2016 Jun 2.

PMID:
27091236
16.

Stress urinary incontinence in female neurological patients: long-term functional outcomes after artificial urinary sphincter (AMS 800TM ) implantation.

Phé V, Léon P, Granger B, Denys P, Bitker MO, Mozer P, Chartier-Kastler E.

Neurourol Urodyn. 2017 Mar;36(3):764-769. doi: 10.1002/nau.23019. Epub 2016 Apr 15.

PMID:
27080729
17.

Management of neurogenic bladder in patients with multiple sclerosis.

Phé V, Chartier-Kastler E, Panicker JN.

Nat Rev Urol. 2016 May;13(5):275-88. doi: 10.1038/nrurol.2016.53. Epub 2016 Mar 31. Review.

PMID:
27030526
18.

Control Cross-sectional Study Evaluating an Antibiotic Prevention Strategy in 30 Pregnancies Under Clean Intermittent Self-catheterization and Review of Literature.

Michau A, Dinh A, Denys P, Levy J, Chartier-Kastler E, Bernard L, Dommergues M, Nizard J.

Urology. 2016 May;91:58-63. doi: 10.1016/j.urology.2016.02.007. Epub 2016 Feb 18. Review.

PMID:
26905030
19.

Étude de l'influence de l'expression de Foxp3 (Forkhead box protein) sur la survie des patients neuro-urologiques ayant une tumeur de vessie.

Phe V, Compérat E, Chartier-Kastler E, Léon P, Cussenot O, Gamé X, Karsenty G, Ruffion A, Drouin S, Rouprêt M.

Prog Urol. 2015 Nov;25(13):849. doi: 10.1016/j.purol.2015.08.267. French. No abstract available.

PMID:
26544462
20.

Évaluation standardisée d'un protocole d'injections intralésionnelles de vérapamil pour maladie de Lapeyronie.

Peyronnet B, Wolff B, Drouin S, Mozer P, Renard-Penna R, Phé V, Chartier-Kastler E, Bitker M, Roupret M.

Prog Urol. 2015 Nov;25(13):814. doi: 10.1016/j.purol.2015.08.197. French. No abstract available.

PMID:
26544392

Supplemental Content

Loading ...
Support Center